Literature DB >> 32040710

Volume loss in the deep gray matter and thalamic subnuclei: a longitudinal study on disability progression in multiple sclerosis.

Stefano Magon1,2, Charidimos Tsagkas3,4, Laura Gaetano3,4, Raihaan Patel5,6, Yvonne Naegelin3, Michael Amann3,4,7, Katrin Parmar3,4, Athina Papadopoulou3,8, Jens Wuerfel4,7, Christoph Stippich9, Ludwig Kappos3, M Mallar Chakravarty5,6,10, Till Sprenger3,11.   

Abstract

BACKGROUND: Volume loss in the deep gray matter (DGM) has been reported in patients with multiple sclerosis (MS) already at early stages of the disease and is thought to progress throughout the disease course.
OBJECTIVE: To investigate the impact and predictive value of volume loss in DGM and thalamic subnuclei on disability worsening in patients MS over a 6-year follow-up period.
METHODS: Hundred and seventy-nine patients with RRMS (132 women; median Expanded Disability Status Scale, EDSS: 2.5) and 50 with SPMS (27 women; median EDSS: 4.5) were included in the study. Patients underwent annual EDSS assessments and annual MRI at 1.5 T. DGM/thalamic subnuclei volumes were identified on high-resolution T1-weighted. A hierarchical linear mixed model for each anatomical DGM area and each thalamic subnucleus was performed to investigate the associations with disability scores. Cox regression was used to estimate the predictive properties of volume loss in DGM and thalamic subnuclei on disease worsening.
RESULTS: In the whole sample and in RRMS, volumes of the thalamus and the striatum were associated with the EDSS; however, only thalamic volume loss was associated with EDSS change at follow-up. Regarding thalamic subnuclei, volume loss in the anterior nucleus, the pulvinar and the ventral anterior nucleus was associated with EDSS change in the whole cohort. A trend was observed for the ventral lateral nucleus. Volume loss in the anterior and ventral anterior nuclei was associated with EDSS change over time in patients with RRMS. Moreover, MS phenotype and annual rates of volume loss in the thalamus and ventral lateral nucleus were predictive of disability worsening.
CONCLUSION: These results highlight the relevance of volume loss in the thalamus as a key metric for predicting disability worsening as assessed by EDSS (in RRMS). Moreover, the volume loss in specific nuclei such as the ventral lateral nucleus seems to play a role in disability worsening.

Entities:  

Keywords:  Deep gray matter; Multiple sclerosis; Thalamic subnuclei; Thalamus; Volumetric MRI

Year:  2020        PMID: 32040710     DOI: 10.1007/s00415-020-09740-4

Source DB:  PubMed          Journal:  J Neurol        ISSN: 0340-5354            Impact factor:   4.849


  48 in total

1.  Thalamic damage and long-term progression of disability in multiple sclerosis.

Authors:  Maria Assunta Rocca; Sarlota Mesaros; Elisabetta Pagani; Maria Pia Sormani; Giancarlo Comi; Massimo Filippi
Journal:  Radiology       Date:  2010-08-19       Impact factor: 11.105

2.  Dynamics of brain iron levels in multiple sclerosis: A longitudinal 3T MRI study.

Authors:  Michael Khalil; Christian Langkammer; Alexander Pichler; Daniela Pinter; Thomas Gattringer; Gerhard Bachmaier; Stefan Ropele; Siegrid Fuchs; Christian Enzinger; Franz Fazekas
Journal:  Neurology       Date:  2015-05-15       Impact factor: 9.910

3.  White matter hemodynamic abnormalities precede sub-cortical gray matter changes in multiple sclerosis.

Authors:  Andrew W Varga; Glyn Johnson; James S Babb; Joseph Herbert; Robert I Grossman; Matilde Inglese
Journal:  J Neurol Sci       Date:  2009-01-31       Impact factor: 3.181

4.  Label-fusion-segmentation and deformation-based shape analysis of deep gray matter in multiple sclerosis: the impact of thalamic subnuclei on disability.

Authors:  Stefano Magon; M Mallar Chakravarty; Michael Amann; Katrin Weier; Yvonne Naegelin; Michaela Andelova; Ernst-Wilhelm Radue; Christoph Stippich; Jason P Lerch; Ludwig Kappos; Till Sprenger
Journal:  Hum Brain Mapp       Date:  2014-02-07       Impact factor: 5.038

5.  Regional grey matter atrophy in clinically isolated syndromes at presentation.

Authors:  R G Henry; M Shieh; D T Okuda; A Evangelista; M L Gorno-Tempini; D Pelletier
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-05-09       Impact factor: 10.154

6.  Neuroimaging and clinical outcomes of oral anticoagulant-associated intracerebral hemorrhage.

Authors:  Georgios Tsivgoulis; Duncan Wilson; Aristeidis H Katsanos; João Sargento-Freitas; Cláudia Marques-Matos; Elsa Azevedo; Tomohide Adachi; Christian von der Brelie; Yoshifusa Aizawa; Hiroshi Abe; Hirofumi Tomita; Ken Okumura; Joji Hagii; David J Seiffge; Vasileios-Arsenios Lioutas; Christopher Traenka; Panayiotis Varelas; Ghazala Basir; Christos Krogias; Jan C Purrucker; Vijay K Sharma; Timolaos Rizos; Robert Mikulik; Oluwaseun A Sobowale; Kristian Barlinn; Hanne Sallinen; Nitin Goyal; Shin-Joe Yeh; Theodore Karapanayiotides; Teddy Y Wu; Konstantinos Vadikolias; Marc Ferrigno; Georgios Hadjigeorgiou; Rik Houben; Sotirios Giannopoulos; Floris H B M Schreuder; Jason J Chang; Luke A Perry; Maximilian Mehdorn; João-Pedro Marto; João Pinho; Jun Tanaka; Marion Boulanger; Rustam Al-Shahi Salman; Hans R Jäger; Clare Shakeshaft; Yusuke Yakushiji; Philip M C Choi; Julie Staals; Charlotte Cordonnier; Jiann-Shing Jeng; Roland Veltkamp; Dar Dowlatshahi; Stefan T Engelter; Adrian R Parry-Jones; Atte Meretoja; Panayiotis D Mitsias; Andrei V Alexandrov; Gareth Ambler; David J Werring
Journal:  Ann Neurol       Date:  2018-10-25       Impact factor: 10.422

7.  Structural MRI correlates of cognitive impairment in patients with multiple sclerosis: A Multicenter Study.

Authors:  Paolo Preziosa; Maria A Rocca; Elisabetta Pagani; Maria Laura Stromillo; Christian Enzinger; Antonio Gallo; Hanneke E Hulst; Matteo Atzori; Deborah Pareto; Gianna C Riccitelli; Massimiliano Copetti; Nicola De Stefano; Franz Fazekas; Alvino Bisecco; Frederik Barkhof; Tarek A Yousry; Maria J Arévalo; Massimo Filippi
Journal:  Hum Brain Mapp       Date:  2016-02-02       Impact factor: 5.038

8.  Demyelination, inflammation, and neurodegeneration in multiple sclerosis deep gray matter.

Authors:  Marco Vercellino; Silvia Masera; Marcella Lorenzatti; Cecilia Condello; Aristide Merola; Alessandra Mattioda; Antonella Tribolo; Elisabetta Capello; Giovanni Luigi Mancardi; Roberto Mutani; Maria Teresa Giordana; Paola Cavalla
Journal:  J Neuropathol Exp Neurol       Date:  2009-05       Impact factor: 3.685

9.  A combined post-mortem magnetic resonance imaging and quantitative histological study of multiple sclerosis pathology.

Authors:  James Kolasinski; Charlotte J Stagg; Steven A Chance; Gabriele C Deluca; Margaret M Esiri; Eun-Hyuk Chang; Jacqueline A Palace; Jennifer A McNab; Mark Jenkinson; Karla L Miller; Heidi Johansen-Berg
Journal:  Brain       Date:  2012-10       Impact factor: 13.501

10.  Deep gray matter volume loss drives disability worsening in multiple sclerosis.

Authors:  Arman Eshaghi; Ferran Prados; Wallace J Brownlee; Daniel R Altmann; Carmen Tur; M Jorge Cardoso; Floriana De Angelis; Steven H van de Pavert; Niamh Cawley; Nicola De Stefano; M Laura Stromillo; Marco Battaglini; Serena Ruggieri; Claudio Gasperini; Massimo Filippi; Maria A Rocca; Alex Rovira; Jaume Sastre-Garriga; Hugo Vrenken; Cyra E Leurs; Joep Killestein; Lukas Pirpamer; Christian Enzinger; Sebastien Ourselin; Claudia A M Gandini Wheeler-Kingshott; Declan Chard; Alan J Thompson; Daniel C Alexander; Frederik Barkhof; Olga Ciccarelli
Journal:  Ann Neurol       Date:  2018-02-06       Impact factor: 10.422

View more
  12 in total

1.  Thalamic atrophy moderates associations among aerobic fitness, cognitive processing speed, and walking endurance in persons with multiple sclerosis.

Authors:  Brian M Sandroff; Robert W Motl; Cristina A F Román; Glenn R Wylie; John DeLuca; Gary R Cutter; Ralph H B Benedict; Michael G Dwyer; Robert Zivadinov
Journal:  J Neurol       Date:  2022-06-19       Impact factor: 6.682

2.  Brainstem lesions are associated with diffuse spinal cord involvement in early multiple sclerosis.

Authors:  Michaela Andelova; Karolina Vodehnalova; Jan Krasensky; Eliska Hardubejova; Tereza Hrnciarova; Barbora Srpova; Tomas Uher; Ingrid Menkyova; Dominika Stastna; Lucie Friedova; Jiri Motyl; Jana Lizrova Preiningerova; Eva Kubala Havrdova; Bénédicte Maréchal; Mário João Fartaria; Tobias Kober; Dana Horakova; Manuela Vaneckova
Journal:  BMC Neurol       Date:  2022-07-19       Impact factor: 2.903

3.  Cerebellar Abnormalities on Proton MR Spectroscopy and Imaging in Patients With Gluten Ataxia: A Pilot Study.

Authors:  Vishwa Rawat; Ritu Tyagi; Inder Singh; Prasenjit Das; Achal Kumar Srivastava; Govind K Makharia; Uma Sharma
Journal:  Front Hum Neurosci       Date:  2022-05-17       Impact factor: 3.473

4.  Classification of multiple sclerosis based on patterns of CNS regional atrophy covariance.

Authors:  Charidimos Tsagkas; Katrin Parmar; Simon Pezold; Christian Barro; Mallar M Chakravarty; Laura Gaetano; Yvonne Naegelin; Michael Amann; Athina Papadopoulou; Jens Wuerfel; Ludwig Kappos; Jens Kuhle; Till Sprenger; Cristina Granziera; Stefano Magon
Journal:  Hum Brain Mapp       Date:  2021-02-24       Impact factor: 5.038

5.  Serum NfL levels in the first five years predict 10-year thalamic fraction in patients with MS.

Authors:  Hrishikesh Lokhande; Mattia Rosso; Shahamat Tauhid; Renxin Chu; Brian C Healy; Shrishti Saxena; Christian Barro; Anu Paul; Mariann Polgar-Turcsanyi; Mark Anderson; Bonnie I Glanz; Harald Kropshofer; Cristina Granziera; David Leppert; Ludwig Kappos; Jens Kuhle; Howard L Weiner; Rohit Bakshi; Tanuja Chitnis
Journal:  Mult Scler J Exp Transl Clin       Date:  2022-01-10

6.  The association between neurodegeneration and local complement activation in the thalamus to progressive multiple sclerosis outcome.

Authors:  Benjamin J Cooze; Matthew Dickerson; Rukshikah Loganathan; Lewis M Watkins; Ethan Grounds; Ben R Pearson; Ryan Jack Bevan; B Paul Morgan; Roberta Magliozzi; Richard Reynolds; James W Neal; Owain W Howell
Journal:  Brain Pathol       Date:  2022-02-07       Impact factor: 7.611

7.  Central nervous system atrophy predicts future dynamics of disability progression in a real-world multiple sclerosis cohort.

Authors:  Charidimos Tsagkas; Yvonne Naegelin; Michael Amann; Athina Papadopoulou; Christian Barro; M Mallar Chakravarty; Laura Gaetano; Jens Wuerfel; Ludwig Kappos; Jens Kuhle; Cristina Granziera; Till Sprenger; Stefano Magon; Katrin Parmar
Journal:  Eur J Neurol       Date:  2021-09-17       Impact factor: 6.288

8.  Contribution of Gray Matter Atrophy and White Matter Damage to Cognitive Impairment in Mildly Disabled Relapsing-Remitting Multiple Sclerosis Patients.

Authors:  Ángela Bernabéu-Sanz; Sandra Morales; Valery Naranjo; Ángel P Sempere
Journal:  Diagnostics (Basel)       Date:  2021-03-23

9.  Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumes.

Authors:  Elisa Colato; Jonathan Stutters; Carmen Tur; Sridar Narayanan; Douglas L Arnold; Claudia A M Gandini Wheeler-Kingshott; Frederik Barkhof; Olga Ciccarelli; Declan T Chard; Arman Eshaghi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2021-04-20       Impact factor: 10.154

10.  Distinctive waves of innate immune response in the retina in experimental autoimmune encephalomyelitis.

Authors:  Andrés Cruz-Herranz; Frederike C Oertel; Kicheol Kim; Ester Cantó; Garrett Timmons; Jung H Sin; Michael Devereux; Nicholas Baker; Brady Michel; Ryan D Schubert; Lakshmisahithi Rani; Christian Cordano; Sergio E Baranzini; Ari J Green
Journal:  JCI Insight       Date:  2021-06-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.